(Q46515354)

English

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

0 references

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

0 references

alcohol dependence

1 reference

based on heuristic

inferred from title

author name string

James L Snyder

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

Thomas G Bowers

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

American Journal of Drug and Alcohol Abuse

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

34

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

449-461

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Experience of a "slip" among alcoholics treated with naltrexone or placebo.

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Methodological characteristics and quality of alcohol treatment outcome studies, 1970-98: an expanded evaluation

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

A critical review of pharmacoeconomic studies of acamprosate

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Efficacy of acamprosate in the treatment of alcohol-dependent outpatients

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence.

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Acamprosate and its efficacy in treating alcohol dependent adolescents

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1080%2F00952990802082198

21 January 2018

Identifiers

10.1080/00952990802082198

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18584575

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46515354&oldid=2115658856"